Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial

[논문]Ah-Young Kim, Seonyoung Park, 이한길, Deborah Baik, Hyeonseok Cho, Sunghwa Cho, Hye-Young Kang, Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial, BMC CANCER, pp.1157- pp.1157 (11월, 2020)

논문 링크: https://pubmed.ncbi.nlm.nih.gov/33243162/

DOI: 10.1186/s12885-020-07629-z